Britain Gets Experimental Drug From Japan to Bolster Hantavirus Response
Britain will use the experimental antiviral to bolster treatment stocks after three deaths and eight confirmed cases were linked to the Hondius cruise liner.
- On Friday, Japan supplied the antiviral drug Avigan to Britain to treat a hantavirus outbreak linked to the Hondius cruise ship, Health Minister Kenichiro Ueno confirmed Monday.
- The outbreak involves the Andes virus, a rare strain capable of human-to-human transmission, which has caused three deaths among eight confirmed cases and two probable infections linked to the ship.
- Originally developed by Toyama Chemical for influenza, favipiravir—sold as Avigan—is unlicensed in Britain and remains an experimental, compassionate treatment for severe hantavirus cases.
- The UK Health Security Agency accepted delivery over the weekend to bolster treatment stocks, though officials emphasize domestic transmission risk remains very low.
- World Health Organization experts report no evidence the virus has become more transmissible, stating the current cluster poses no pandemic threat to the global population.
18 Articles
18 Articles
Experimental Drug Delivered to UK Amid Hantavirus Outbreak Linked to Cruise Liner
Britain received favipiravir from Japan to combat a hantavirus outbreak connected to the Hondius cruise ship. The UK Health Security Agency clarified that although favipiravir is experimental for hantavirus use, it might improve treatment stocks. The risk of transmission in the UK remains low with three fatalities reported.
Britain gets experimental drug from Japan to bolster hantavirus response
Britain has received supplies of the antiviral drug favipiravir from Japan as part of its ongoing response to a deadly hantavirus outbreak linked to the Hondius cruise liner, the UK Health Security Agency said on Monday.
Coverage Details
Bias Distribution
- 57% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium











